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IgG4-related kidney disease (IgG4-RKD) occasionally progresses to chronic renal 
failure and is pathologically characterized by IgG4-positive lymphoplasmacyte-rich 
tubulointerstitial nephritis with storiform fibrosis (bird‟s-eye pattern fibrosis). Although 
radiology reveals a heterogeneous distribution of affected areas in this disease, their true 
distribution within the whole kidney is still unknown because of difficulty in estimating 
this from needle biopsy samples. 
Using 5 autopsy specimens, the present study histologically characterized the 
distribution and components of interstitial inflammation and fibrosis in IgG4-RKD. 
Interstitial lymphoplasmacytic infiltration or fibrosis was observed in a variety of 
anatomical locations such as intracapsular, subcapsular, cortical, perivascular, and 
perineural regions heterogeneously in a patchy distribution. They tended to be more 
markedly accumulated around medium- and small-sized vessels. Storiform fibrosis was 
limited to the cortex. Immunostaining revealed nonfibrillar collagens (collagen IV and 
VI) and fibronectin predominance in the cortical lesion, including storiform fibrosis. In 
contrast, fibril-forming collagens (collagen I and III), collagen VI and fibronectin were 
the main components in the perivascular lesion. In addition, alpha-smooth muscle 














decreased with progression, suggesting that myofibroblasts produce extracellular 
matrices forming a peculiar fibrosis.  
In conclusion, perivascular inflammation or fibrosis of medium- and small-sized 
vessels is a newly identified pathological feature of IgG4- KD. Because storiform 
fibrosis contains mainly nonfibrillar collagens, “interstitial fibrosclerosis” would be a 
suitable term to reflect this. The relation between the location and components of 
fibrosis determined in whole kidney samples provides new clues to the pathophysiology 
underlying IgG4-RKD.  
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IgG4-related kidney disease (IgG4-RKD) is a major manifestation of IgG4-related 
disease (IgG4-RD) [1,2]. The typical histology, IgG4-positive plasma cell (PC)-rich 
tubulointerstitial nephritis (TIN), occasionally progresses to chronic renal failure [3,4].  
One basic pathological feature of IgG4-RKD is a curious distribution of its 
inflammation. Radiologically, the lesions distribute heterogeneously within the kidney 
such as capsule, cortex, medulla, and renal pelvis [1]. Reflecting the radiological 
findings, histology shows its specific features: a clear demarcation between lesions and 
non-lesions, and extension of a lesion often beyond the renal capsule [3,5]. However, it 
remains unknown how IgG4-positive PCs infiltrate heterogeneously in the kidney 
structures because of the insufficient size of tissue specimens obtainable by needle 
biopsy. In this regard, autopsy specimens are ideal for analyzing the distribution of 
inflammation and fibrosis. 
In addition to location, the interstitial fibrosis, called „storiform fibrosis‟ or „bird‟s-eye 
pattern fibrosis‟, is another important disease-specific histological hallmark of 
IgG4-RKD that clearly distinguishes IgG4-related from non-IgG4-related TIN [3,5]. 
Electron microscopic analysis suggests that storiform fibrosis contains more 














fibrosis may consist of different ECM proteins from other stages of fibrosis in 
IgG4-RKD and non-IgG4-related TIN. However, it remains undetermined whether 
different stages of interstitial lesions, including storiform fibrosis, contain the same 
ECM proteins.  
In the present study, we histologically identified the characteristic distribution of 
interstitial inflammation and fibrosis in IgG4-RKD, using autopsy kidneys. 
Subsequently, we analyzed and compared the characteristic components of interstitial 
fibrosis according to the locations by immunostaining. Our findings may facilitate better 
understanding of the pathophysiology of IgG4-RKD. 
 
2. Materials and Methods 
2.1. Subjects 
Five autopsy derived whole kidneys from IgG4-RKD patients were enrolled 
(Kanazawa University, Nagaoka Red Cross Hospital, Nagaoka Chuo General Hospital, 
Toranomon Hospital and Okayama University). The diagnoses of IgG4-RKD and 
IgG4-RD were made according to established diagnostic criteria [2,4,6]. Serum samples 
were also obtained at the time of diagnosis of IgG4-RD. Cases 3 and 4 were described 














diabetic nephropathy (n = 2), and benign nephrosclerosis (n = 2) were used to compare 
ECM proteins with those of IgG4-related TIN. The study was approved by the ethics 
committee of Kanazawa University (No. 2013-833). 
 
2.2. Histochemical and immunohistochemical analyses 
Autopsies were performed 2.2, 1.5, 8, 1.5, and 8 h after death in cases 1 to 5, 
respectively. All samples were fixed in formaldehyde and embedded in paraffin blocks, 
and were used for hematoxylin and eosin, periodic acid-Schiff, periodic acid 
methenamine silver (PAM), Masson‟s Trichrome (MT) staining, and immunostaining. 
Specific primary antibodies for immunostaining were as follows: monoclonal mouse 
anti-human IgG4 antibody (clone HP6025; ready-to-use; Nichirei Bioscience, Tokyo, 
Japan), monoclonal mouse anti-human CD138 antibody (clone B-A38; 1:100; AbD 
Serotec, Oxford, UK), monoclonal mouse anti-human collagen I antibody (clone 
COL-1; 1:100; Abcam, Cambridge, UK), polyclonal rabbit anti-human collagen III 
antibody (1:400; Abcam), polyclonal rabbit anti-human collagen IV antibody (1:200; 
Abcam), monoclonal mouse anti-human collagen V antibody (clone 1E2-E4/Col5; 1:50; 
Abcam), polyclonal rabbit anti-human collagen VI antibody (1:100; Abcam), polyclonal 














monoclonal mouse anti-human alpha-smooth muscle actin (α-SMA) antibody (clone 
1A4; 1:400; Sigma-Aldrich, MO, USA). For immunostaining, antigen was retrieved by 
a microwave (10 mM citrate buffer; pH 6.0) for IgG4, CD138, collagen I, fibronectin 
and α-SMA, or 100 µg/mL of proteinase K (Wako Pure Chemical Industries, Osaka, 
Japan) for collagen III, IV, V and VI. Thereafter, primary antibodies of rabbit origin 
were incubated in EnVision labeled polymer-horseradish peroxidase (Dako), and 
primary antibodies of mouse origin were incubated in a Histofine kit (Nichirei 
Bioscience) followed by reaction with peroxidase-conjugated streptavidin (Nichirei 
Bioscience). Peroxidase activity was visualized using a liquid diaminobenzidine 
substrate (Dako). Hematoxylin was used to stain nuclei. 
 Interstitial inflammation was classified according to the stage and location. Stages 
were defined as: stage A, acute interstitial nephritis pattern with minimal interstitial 
fibrosis; stage B, active cellular infiltration with mild but distinct expansile interstitial 
fibrosis; stage C, interstitial fibrosis dominant with mild cellular infiltration; stage D, 
advanced interstitial fibrosis with less cellular infiltration [3,4]. Storiform fibrosis or 
bird‟s-eye pattern fibrosis is defined as an irregular pattern of fibrosis resembling the 
spokes of a cartwheel with infiltrating cells radiating from the center [3,9]. Locations 














and perineural lesions), perivasculature, perinerve and medulla.  
For comparison of different staining at the same location, we obtained synchronized 
images using Nano-Zoomer 2.1S (Hamamatsu Photonics, Hamamatsu, Japan). 
 
2.3. Statistics 
All data are presented as absolute numbers or means ± standard errors. Statistical 
differences between two or more than three groups were evaluated using unpaired 




3.1. Clinical profiles 
The patients were all Japanese males with an average age of 71.2 ± 2.2 (range 64-76) 
years at the time of diagnosis of IgG4-RD (Table 1). The mean intervals from diagnosis 
to death were 63.2 ± 15.5 (range 1-108) months. All patients demonstrated serum IgG 
and IgG4 elevations (IgG mean 3,886 mg/dL, range 2,430-4,813 mg/dL; IgG4 mean 
1,284 mg/dL, range 319-1,750 mg/dL). Four of the 5 cases (80%) had 














gland, lung, liver, bile duct, aorta, retroperitoneum, lymph nodes, prostate gland, and 
skin. Two patients (40%; cases 1 and 2) were receiving prednisolone at the time of death. 
The other 2 patients (cases 4 and 5) were receiving chemotherapy for malignancy. The 
causes of death were sepsis in 2 cases and sudden death of unknown cause, 
nonocclusive mesenteric ischemia and recurrence of a mucinous cystadenocarcinoma of 
the appendix with peritoneal dissemination in one each of the remaining 3 cases.  
 
3.2. Histopathological features 
Microscopically, all cases showed dense interstitial lymphoplasmacytic infiltration 
and/or fibrosis (Table 2). In 2 of 5 specimens without corticosteroid (cases 3 and 5), 
storiform fibrosis was present (Fig. 1A). Obliterative phlebitis or lymphoid follicles 
were absent in all cases. Lymphoplasmacyte infiltration or fibrosis was detected around 
interlobar, arcuate or interlobular artery segments (width 200-500 μm) or veins in all 
cases (Table 2 and Fig. 1C-F). Two patients who had received long-term corticosteroid 
therapy (cases 1 and 2) showed mild and patchy infiltration of lymphoplasmacytes and 
mild phlebitis, but had a large fibrotic area lacking tubules with few remnant glomeruli 
and arteries (Fig. 1, G and H). 














subcapsule in 3, cortex and perivasculature in 5, perinerve in one, but in the medulla in 
none (Table 3). Lymphoplasmacytic infiltration or fibrosis was located mainly in the 
cortex and perivasculature. Of note is that each specimen contained a variety of stages 
of inflammation in different locations and that storiform fibrosis was limited to the 
cortex. 
By immunohistochemistry, a marked infiltration of IgG4-positive cells was 
demonstrated in the tubulointerstitium (mean IgG4 counts, 63.4; range, 3.4-116/high 
power field [HPF]; Table 2 and Fig. 1B) and the IgG4/CD138 ratio was increased 
(mean IgG4/CD138 ratio, 68.2%; range 14-110%). From these data, 4 of 5 patients 
(cases 1, 3-5) satisfied diagnostic criteria for IgG4-RD and IgG4-RKD, and the 
consensus statement on the pathology of IgG4-RD [2,4,6,9]. The remaining one who 
had received long-term corticosteroid (case 2) showed little lymphoplasmacytic 
infiltration at autopsy (IgG4-positive cell count, 3.4/HPF; IgG4/CD138 ratio, 14%), but 
numerous IgG4-positive PCs infiltrated the tubulointerstitium in the kidney biopsy 
specimen.  
 
3.3. Location and stage dependent components of interstitial fibrosis 














IgG4-RKD using standard staining and immunohistochemistry (Fig. 2, 3 and Table 4).  
 Intracapsular lesions showed stages A and D without storiform fibrosis. At stage D, 
PAM-positive and MT-blue apparent fibers were predominant, and were stained by 
collagen I and fibronectin. Subcapsular lesions showed stages B and D without 
storiform fibrosis. In these lesions, fibrosis was PAM-negative and was stained by 
fibronectin. Cortical lesions revealed all stages including storiform fibrosis. Thin fibers 
were apparent at stage B and subsequently formed thick fibers and encircled infiltrating 
lymphoplasmacytes at stage C (storiform fibrosis), and finally a fiber-rich lesion formed 
stage D. The fibers were PAM-positive and MT-blue, and were stained by collagen IV, 
VI and fibronectin predominantly, but less with collagen I and III. Perivascular lesions 
showed stages A, B, and D, but no storiform fibrosis. Thin fibers similar to those in the 
cortical lesions appeared at stage B. At stage D, biphasic fibers were predominant 
components showing PAM-negative MT-weak blue and PAM-positive MT-strong blue 
pictures. The former fibers consisted of collagen VI and fibronectin, and collagen I and 
III were added to the latter. Perineural lesions showed only stage B. PAM-positive and 
MT-blue fibers appeared that is stained with collagen I and III. No specimens contained 
collagen V in any locations or stages. 














also performed immunostaining in kidney needle biopsy specimens of non-IgG4-related 
TIN, including idiopathic TIN, diabetic nephropathy, and benign nephrosclerosis (Suppl 
Fig.). In the cortex, interstitial fibrosis tended to contain more collagen I than collagen 
III, IV, VI and fibronectin. The components did not differ between the etiologies of 
non-IgG4-related TIN. 
 
3.4. Decrease of myofibroblasts with advancing stage  
We investigated interstitial α-SMA-positive cell infiltration according to the location 
and stage. The number of α-SMA-positive cells did not differ at the same stage in any of 
the locations. With regard to the stage, the number of α-SMA-positive cells was 
significantly higher in stage A and B, and decreased with advancing stage (stage A, 72.4 
± 12.3; stage B, 50.3 ± 6.4; stage C, 31.4 ± 6.1; stage D; 12.6 ± 4.6/HPF; Fig. 4). 
 
4. Discussion and Conclusions 
In the present study, analysis of autopsy specimens clarified characteristic locational 
features of inflammation and fibrosis in IgG4-RKD. Light microscopy revealed that 
interstitial inflammation or fibrosis was located mainly in the cortical and perivascular 














IgG4-related periaortitis which shows IgG4-positive PC infiltration in the aortic 
adventitia [10,11]. In addition to aortic lesions, IgG4-RD can also affect coronary artery, 
forming as a periarteritis [12,13]. These similarities of perivascular lesions suggest that 
lymphoplasmacytic infiltration extends along the adventitia of large-, medium-, and 
then small-sized arteries, forming a heterogeneous distribution in the involved organs 
including kidney in IgG4-RD. Since few reports have focused on the presence or 
absence of periarterial lesions in individual affected organs such as pancreas, further 
studies are needed to evaluate the significance of periarterial lesions in IgG4-RD. In 
addition, further studies using animal models are needed to confirm or refute the 
hypothesis that perivascular inflammation underlies the pathophysiology of IgG4-RKD.  
Another finding in our study is that mixed stages are present in the same kidney in 
different locations. Histology contained areas of active inflammation with background 
interstitial fibrosis, even after the achievement of remission by corticosteroid therapy. 
These findings are important, because clinically inactive but histologically active 
inflammation may result in extension of interstitial fibrosis and renal dysfunction.  
Storiform fibrosis (bird‟s-eye pattern fibrosis) is a characteristic pathological feature of 
IgG4-RKD; however, its localization and accumulated protein are unknown. We found 














nonfibrillar ECM proteins. Collagen, a representative ECM protein, is classified as 
fibril-forming, network-forming, beaded-filament-forming, and other collagens by their 
function and domain homologies [14]. Immunostaining analysis in the present study 
revealed that the cortical lesions, including storiform fibrosis, contained mainly 
network-forming (collagen IV) and beaded-filament-forming collagens (collagen VI), 
while the perivascular lesions contained fibril-forming collagens (collagen I and III). In 
contrast, renal fibrosis in non-IgG4-related TIN consists mainly of fibril-forming 
collagens (collagen I and III) in our study and confirmed previous reports [15,16]. Thus, 
the cortical lesions in IgG4-RKD have different components from those of 
non-IgG4-RD-derived renal fibrosis. In addition, a previous electron microscopic study 
showed that storiform fibrosis contained low-dense matrix components in addition to 
interstitial-type collagen fibrils [3], supporting our immunohistochemical findings. Thus, 
storiform fibrosis would be specific in the point of nonfibrillar collagen predominance, 
compared to interstitial fibrosis of non-IgG4-related TIN which has fibril-forming 
collagen predominance. We would like to propose that the character of storiform 
fibrosis could be described as „fibrosclerosis‟ or „sclerosing fibrosis‟ to emphasize the 
ECM-rich composition in addition to fibrous components in IgG4-RKD.  














perivascular lesions of IgG4-RKD. We identified α-SMA-positive cells, a typical 
marker of myofibroblasts [15], among lymphoplasmacytes in the early phase, which 
decreased in parallel with advancing stage. Electron microscopy also revealed 
myofibroblasts among lymphoplasmacyte infiltrates in the early phase [3]. The number 
of tissue α-SMA-positive cells and amount of collagen accumulation are correlated with 
the disease activity of IgG4-RD [17]. Myofibroblasts produce collagen IV and 
fibronectin in addition to collagen I and III [18,19]. These findings suggest that 
myofibroblasts are a major source of ECMs in IgG4-RD. Furthermore, a variety of 
studies using rodent models have indicated that myofibroblasts have multiple origins 
such as resident fibroblasts, bone marrow derived fibroblasts, pericytes, 
epithelial-mesenchymal transition from tubular cells, and endothelial-mesenchymal 
transition [20,21]. These different origins of myofibroblasts may associate with the 
production of different ECMs according to the locations even in the same profibrotic 
cytokine environment including transforming growth factor-beta (TGF-β), which is 
speculated to be the main cytokine for organ fibrogenesis in IgG4-RKD [16,22]. In the 
analyses of fibrosis in other involved organs of IgG4-RD, some new findings were 
clarified. One group found that epithelial-mesenchymal transition may associate with 














showed in studies on IgG4-related sialadenitis that M2-type macrophages and mast cells 
are other contributors to organ fibrogenesis [24-26]; however, it remains undetermined 
whether these cells and epithelial-mesenchymal transition contribute to the fibrogenesis 
of IgG4-RKD. Our data are limited to IgG4-RKD, precluding any conclusion as to 
whether storiform fibrosis in other organs involved by IgG4-RD contain characteristic 
ECM components. 
Cytokine environment would determine the type of ECMs produced by myofibroblasts, 
forming characteristic interstitial fibrosis in IgG4-RKD. The major cytokine is TGF-β 
which is secreted by regulatory T (Treg) cells [27,28]. In IgG4-RKD, quantitative 
RT-PCR and immunostaining studies have shown that TGF-β mRNA was overexpressed 
in the biopsy specimens of IgG4-RKD and that Treg cells expressed TGF-β in the 
interstitium and the number of Treg cells was correlated with IgG4-positive PCs 
infiltration [16,22]. These findings suggest that Treg-mediated TGF-β affects 
fibrogenesis in IgG4-RKD. TGF-β is not specific for IgG4-RKD because this cytokine 
is also expressed in many chronic kidney diseases as a common pathway for 
progression of interstitial fibrosis [15]. Therefore, our finding, namely that storiform 
fibrosis has characteristic ECMs, suggests that another specific cytokine may also 














In conclusion, autopsy specimens indicated that perivascular lymphoplasmacytic 
infiltration or fibrosis of medium- and small-sized vessels would characterize the 
distribution and pathophysiology of IgG4-RKD. Since our findings showed a 
predominant component of nonfibrillar collagens as storiform fibrosis, we suggest that 
this lesion be referred to as fibrosclerosis. Our findings may provide further insight into 
the pathogenesis of IgG4-RKD. 
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Fig. 1 Histopathological findings of IgG4-related kidney disease in autopsy cases. A: 
Storiform fibrosis (bird‟s-eye pattern fibrosis). Infiltrating lymphoplasmacytes are 
encircled by periodic-acid methenamine silver (PAM)-strong positive thick fibers (Case 
no. 5, PAM staining, original magnification×200). B: Immunostaining for IgG4. Dense 
IgG4-positive cells infiltrate in the interstitium (Case no. 5, original magnification×400). 
C and D: Fiber-rich interstitial lesions are observed around arcuate and interlobular 
artery (Case no. 2, PAM staining, original magnifications C, ×3; D, ×25). E and F: 
Fiber-rich interstitial lesions are also observed around arcuate vein (Case no. 4, PAM 
staining, original magnifications E, ×12.5; F, ×25). G and H: Acellular fibrous lesion 
with clear demarcation is observed in intracapsule and subcapsule (Case no. 1, 
Masson‟s Trichrome staining, original magnifications: G, ×3; H, ×25). 
 
Fig. 2 Immunostaining for interstitial inflammation and fibrosis of intracapsular, 
subcapsular, and perineural lesions in IgG4-related kidney disease patients. Depicted 
stages and locations were as follows: intracapsular lesions, stage D (Case no. 1); 
subcapsular lesions, stage D (Case no. 1); perineural lesions, stage B (Case no. 3). 














dominant in subcapsular lesions. Collagen I and III were dominant in perineural lesions. 
Original magnification×200. 
 
Fig. 3 Immunostaining for interstitial inflammation and fibrosis of perivascular and 
cortical lesions in IgG4-related kidney disease patients. Depicted stages and locations 
were as follows: cortex lesions, stage A+B (Case no. 5); cortex lesions, stage C (Case 
no. 5); perivascular lesions, stage A+B (Case no. 1); perivascular lesions, stage D (Case 
no. 4). Collagen IV, VI and fibronectin were dominant in cortical lesions, including 
storiform fibrosis, whereas collagen I, VI and fibronectin were dominant in perivascular 
lesions. Original magnification×200. 
 
Fig. 4 Alpha-smooth muscle actin (α-SMA)-positive cell infiltration according to stage. 
A: Representative images of immunostaining for α-SMA according to the stage. 
Original magnification×400. B: Comparison of α-SMA-positive cells among the stages. 
The number of α-SMA-positive cells decreased with increasing stage. *p <0.05. Stage A, 








































































1 Male 67 108 4,803 319 56 15 NA Sa, 
Ao/RPF, 
Lu, Ly 
- + - 5 
2 Male 64 69 4,001 1,340 55 2 10 Pa - + - 5 






- - - 0 
4 Male 76 67 3,381 1,520 59 5 28 Pa, Sa, 
Lu, Ly 
Lung cancer - Chem
o 
0 












Abbreviations: CS, corticosteroid; PSL, prednisolone; NA, not available; Sa, salivary 



















































1 38.4 48 - + - ++ 
2 3.4 14 - - +++ + 
3 115.8 83 + +++ - +++ 
4 80 86 - +++ - +++ 
5 77.8 110 + +++ - +++ 


















Intracapsule Subcapsule Cortex Perivasculature Perinerve Medulla 
1 D D B A + B ― None 
2 A B + D D A + B + D ― None 
3 ― ― A + B 
+ C 
B B None 
4 None B None A + B + D ― None 
5 ― ― A + B 
+ C 
A + B ― None 















Table 4. Components in interstitial fibrosis according to stage and distribution 
 
Location/Stages Stage A Stage B Stage C Stage D 
Intracapsule Negative ― ― Col I, FN 
Subcapsule Negative FN ― FN 
Cortex Negative Col IV, VI, FN Col III, IV, VI, 
FN 
Col III, IV, VI, 
FN 
Perivascular Negative Col I, III, IV, 
VI, FN 
― Col I, III, VI, 
FN 
Perinerve Negative Col I, III ― ― 
Medulla ― ― ― ― 
Abbreviations: Col, collagen; FN, fibronectin; ―, no sample was obtained; Negative, 
no lesions existed in sample 
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